Tuesday, January 7, 2014

Dealing With a Triple Negative Breast Cancer

Breast cancer is a leading killer of women and while great steps have been taken to prevent, detect, and cure it, it is still an issue in the health care community. Diagnostic imaging plays a vital part in the detection of breast cancer and in establishing the proper treatment program for patients being affected by it. Often times it’s extremely difficult to treat breast cancer once it’s past a certain point. When breast cancer is categorized as a triple negative it’s fair to say that there will likely not be a tomorrow.

A recent article published by auntminnie.com stated that triple negative breast cancer “accounts for 10% to 20% of all breast cancers, but it causes a relatively large proportion of deaths and has a high rate of distant metastases at diagnosis.” This simply means that within the percentage of breast cancers it covers, it kills people who suffer from it. MRI and CT scans are being linked to the appearance of triple breast cancer. The link is in the fact that a specific type of enhanced MRI and CT scan can help patient prognosis.

As is the case with many complex conditions early detection plays a role in developing a positive prognosis. The difficulty lies in how the body will react to treatment given the fact that treatment is sometimes incredibly counter productive. This particular link between imaging and cancer was found after an exhaustive study was conducted over a significant period of time. It was stated that “117 invasive breast cancers in 117 patients, with an average tumor size of 3.8 cm. Volume, grade, hormone receptor, and human epidermal growth factor receptor 2 (HER2) status were available for 110 tumors (94%), while hormone receptor and HER2 status were available for 115 tumors (98%). Twenty-four lesions (20%) demonstrated the triple-negative phenotype.” In order to arrive at their conclusions, the study was conducted to a point where everything involved was factored in correctly.

What does not help the study is a limitation in population. There are multiple other factors that range from age to allergies according to the study. According to the article “The authors cited several limitations of the study, including a sample of patients mostly with advanced disease.” Therefore, the ability to generalize our results to the breast cancer population at large is limited.”  

Only the future can tell what’s going to happen with this particular development. Hopefully there will be a greater portion of early detection result treatments with the MRI and CT scans suggested by this study.

If you have any questions about diagnostic imaging procedures please feel free to give us a call. We here at Clermont Radiology look forward to answering any questions you may have. Our commitment to patient satisfaction and top quality service has never been stronger.     


Charla Hurst
General Operations Manager

Charla@ClermontRadiology.com  
352-241-6100 



References:


No comments:

Post a Comment